Stay updated with breaking news from Research Integrity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On October 5, 2023, the Office of Research Integrity (ORI) of the Department of Health and Human Services (HHS) issued a notice of proposed rulemaking to update the Public Health...
Scientists are calling for stage 3 clinical trials of an Alzheimer's drug to be scrapped after a report highlighted serious doubts about the legitimacy of research that helped the medicine reach that stage.
A professor at the City College of New York engaged in “significant research misconduct,” an expert committee concluded.
Cassava Sciences Inc (NASDAQ: SAVA), the Alzheimer-focused firm, is facing further controversy as a recent investigation by the City University of New York (CUNY) has implicated neuroscientist Hoau-Yan Wang, a long-time collaborator of Cassava, in scientific misconduct related to 20 research papers.&nb
Cassava Sciences Inc (NASDAQ:SAVA), the Alzheimer-focused firm, is facing further controversy as a recent investigation by the City Universit...